Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines
Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cyclo...
Gespeichert in:
Veröffentlicht in: | Angewandte Chemie International Edition 2023-08, Vol.62 (34), p.e202304672-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 34 |
container_start_page | e202304672 |
container_title | Angewandte Chemie International Edition |
container_volume | 62 |
creator | Liu, Yaowen Dietl, Martin C. Heckershoff, Robin Han, Chunyu Shi, Hongwei Rudolph, Matthias Rominger, Frank Caligiuri, Isabella Asif, Kanwal Adeel, Muhammad Scattolin, Thomas Hashmi, A. Stephen K. |
description | Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones.
A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions. |
doi_str_mv | 10.1002/anie.202304672 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2816758090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2851805106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</originalsourceid><addsrcrecordid>eNqFkc1qFTEYhoNYbG27dSkBNwWZ0_zNJF0Opz8eLO3CupIyZJIMpGaSY5KpTle9AcFr9EpMObVCN67yJXmelw9eAN5gtMAIkUPprVkQRChiDScvwA6uCa4o5_RlmRmlFRc13gavU7opvBCoeQW2KSeIEVHvgJ9nwenf97-WMks33xkNT0McpYNf2HtyDZezckFqbbMNHsoEW6VMSjAH2Pps8zSGWOxWZXtr4Ke1jUEVxSp4-cN6HZxJcIhhhK37OvtykV7DVZLZ-qIdm1g0DT-abEdbvvfA1iBdMvuP5y74fHpytfxQnV-erZbteaUYpqTSDaJcY450j6iiQ03YoLEYkEaMGyNk3fRYlWcue0GGgRmOG8YYkULJvunpLjjY5K5j-DaZlLvRJmWck96EKXVE4IbXAh2hgr57ht6EKfqyXaFqLFCNUVOoxYZSMaQUzdCtox1lnDuMuoeiuoeiuqeiivD2MXbqR6Of8L_NFOBoA3y3zsz_ievai9XJv_A_N8ajPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2851805106</pqid></control><display><type>article</type><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><source>Access via Wiley Online Library</source><creator>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</creator><creatorcontrib>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</creatorcontrib><description>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones.
A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.202304672</identifier><identifier>PMID: 37204285</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Additives ; Alkynes ; Antitumor Activity ; Biocompatibility ; Biological activity ; Carbamates (tradename) ; Catalysts ; Cycloaddition ; Functional groups ; Gold ; Gold Catalysis ; Imines ; Isatin-Derived Ketimines ; Spirocarbamates ; Tumor cell lines ; Tumor cells ; Tumors</subject><ispartof>Angewandte Chemie International Edition, 2023-08, Vol.62 (34), p.e202304672-n/a</ispartof><rights>2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH</rights><rights>2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</citedby><cites>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</cites><orcidid>0000-0002-6720-8602</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.202304672$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.202304672$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37204285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yaowen</creatorcontrib><creatorcontrib>Dietl, Martin C.</creatorcontrib><creatorcontrib>Heckershoff, Robin</creatorcontrib><creatorcontrib>Han, Chunyu</creatorcontrib><creatorcontrib>Shi, Hongwei</creatorcontrib><creatorcontrib>Rudolph, Matthias</creatorcontrib><creatorcontrib>Rominger, Frank</creatorcontrib><creatorcontrib>Caligiuri, Isabella</creatorcontrib><creatorcontrib>Asif, Kanwal</creatorcontrib><creatorcontrib>Adeel, Muhammad</creatorcontrib><creatorcontrib>Scattolin, Thomas</creatorcontrib><creatorcontrib>Hashmi, A. Stephen K.</creatorcontrib><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><title>Angewandte Chemie International Edition</title><addtitle>Angew Chem Int Ed Engl</addtitle><description>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones.
A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</description><subject>Additives</subject><subject>Alkynes</subject><subject>Antitumor Activity</subject><subject>Biocompatibility</subject><subject>Biological activity</subject><subject>Carbamates (tradename)</subject><subject>Catalysts</subject><subject>Cycloaddition</subject><subject>Functional groups</subject><subject>Gold</subject><subject>Gold Catalysis</subject><subject>Imines</subject><subject>Isatin-Derived Ketimines</subject><subject>Spirocarbamates</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><subject>Tumors</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkc1qFTEYhoNYbG27dSkBNwWZ0_zNJF0Opz8eLO3CupIyZJIMpGaSY5KpTle9AcFr9EpMObVCN67yJXmelw9eAN5gtMAIkUPprVkQRChiDScvwA6uCa4o5_RlmRmlFRc13gavU7opvBCoeQW2KSeIEVHvgJ9nwenf97-WMks33xkNT0McpYNf2HtyDZezckFqbbMNHsoEW6VMSjAH2Pps8zSGWOxWZXtr4Ke1jUEVxSp4-cN6HZxJcIhhhK37OvtykV7DVZLZ-qIdm1g0DT-abEdbvvfA1iBdMvuP5y74fHpytfxQnV-erZbteaUYpqTSDaJcY450j6iiQ03YoLEYkEaMGyNk3fRYlWcue0GGgRmOG8YYkULJvunpLjjY5K5j-DaZlLvRJmWck96EKXVE4IbXAh2hgr57ht6EKfqyXaFqLFCNUVOoxYZSMaQUzdCtox1lnDuMuoeiuoeiuqeiivD2MXbqR6Of8L_NFOBoA3y3zsz_ievai9XJv_A_N8ajPA</recordid><startdate>20230821</startdate><enddate>20230821</enddate><creator>Liu, Yaowen</creator><creator>Dietl, Martin C.</creator><creator>Heckershoff, Robin</creator><creator>Han, Chunyu</creator><creator>Shi, Hongwei</creator><creator>Rudolph, Matthias</creator><creator>Rominger, Frank</creator><creator>Caligiuri, Isabella</creator><creator>Asif, Kanwal</creator><creator>Adeel, Muhammad</creator><creator>Scattolin, Thomas</creator><creator>Hashmi, A. Stephen K.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6720-8602</orcidid></search><sort><creationdate>20230821</creationdate><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><author>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Additives</topic><topic>Alkynes</topic><topic>Antitumor Activity</topic><topic>Biocompatibility</topic><topic>Biological activity</topic><topic>Carbamates (tradename)</topic><topic>Catalysts</topic><topic>Cycloaddition</topic><topic>Functional groups</topic><topic>Gold</topic><topic>Gold Catalysis</topic><topic>Imines</topic><topic>Isatin-Derived Ketimines</topic><topic>Spirocarbamates</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yaowen</creatorcontrib><creatorcontrib>Dietl, Martin C.</creatorcontrib><creatorcontrib>Heckershoff, Robin</creatorcontrib><creatorcontrib>Han, Chunyu</creatorcontrib><creatorcontrib>Shi, Hongwei</creatorcontrib><creatorcontrib>Rudolph, Matthias</creatorcontrib><creatorcontrib>Rominger, Frank</creatorcontrib><creatorcontrib>Caligiuri, Isabella</creatorcontrib><creatorcontrib>Asif, Kanwal</creatorcontrib><creatorcontrib>Adeel, Muhammad</creatorcontrib><creatorcontrib>Scattolin, Thomas</creatorcontrib><creatorcontrib>Hashmi, A. Stephen K.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yaowen</au><au>Dietl, Martin C.</au><au>Heckershoff, Robin</au><au>Han, Chunyu</au><au>Shi, Hongwei</au><au>Rudolph, Matthias</au><au>Rominger, Frank</au><au>Caligiuri, Isabella</au><au>Asif, Kanwal</au><au>Adeel, Muhammad</au><au>Scattolin, Thomas</au><au>Hashmi, A. Stephen K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew Chem Int Ed Engl</addtitle><date>2023-08-21</date><risdate>2023</risdate><volume>62</volume><issue>34</issue><spage>e202304672</spage><epage>n/a</epage><pages>e202304672-n/a</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><abstract>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones.
A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37204285</pmid><doi>10.1002/anie.202304672</doi><tpages>8</tpages><edition>International ed. in English</edition><orcidid>https://orcid.org/0000-0002-6720-8602</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1433-7851 |
ispartof | Angewandte Chemie International Edition, 2023-08, Vol.62 (34), p.e202304672-n/a |
issn | 1433-7851 1521-3773 |
language | eng |
recordid | cdi_proquest_miscellaneous_2816758090 |
source | Access via Wiley Online Library |
subjects | Additives Alkynes Antitumor Activity Biocompatibility Biological activity Carbamates (tradename) Catalysts Cycloaddition Functional groups Gold Gold Catalysis Imines Isatin-Derived Ketimines Spirocarbamates Tumor cell lines Tumor cells Tumors |
title | Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T16%3A03%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gold%E2%80%90Catalyzed%20Formal%20%5B4+2%5D%20Cycloaddition%20as%20Access%20to%20Antitumor%E2%80%90Active%20Spirocyclic%20Oxindoles%20from%20Alkynes%20and%20Isatin%E2%80%90Derived%20Ketimines&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Liu,%20Yaowen&rft.date=2023-08-21&rft.volume=62&rft.issue=34&rft.spage=e202304672&rft.epage=n/a&rft.pages=e202304672-n/a&rft.issn=1433-7851&rft.eissn=1521-3773&rft_id=info:doi/10.1002/anie.202304672&rft_dat=%3Cproquest_cross%3E2851805106%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2851805106&rft_id=info:pmid/37204285&rfr_iscdi=true |